Drug Type Small molecule drug |
Synonyms LPH 101, LPH101 |
Target |
Action agonists |
Mechanism 5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurodegenerative Diseases | Preclinical | Denmark | 01 May 2026 | |
| Substance Abuse | Preclinical | Denmark | 01 May 2026 |





